| Literature DB >> 28403365 |
Luciane Geanini Pena Dos Santos1, Wilson Tadeu Felippe1, Beatriz Dulcineia Mendes de Souza1, Andrea Cristina Konrath2, Mabel Mariela Rodríguez Cordeiro3, Mara Cristina Santos Felippe1.
Abstract
OBJECTIVES: To assess tooth crown's color after intracanal treatment with triple antibiotic paste (TAP) or calcium hydroxide (CH); cervical sealing with glass ionomer cement (GIC) or mineral trioxide aggregate (MTA); and bleaching with carbamide peroxide.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28403365 PMCID: PMC5393545 DOI: 10.1590/1678-77572016-0398
Source DB: PubMed Journal: J Appl Oral Sci ISSN: 1678-7757 Impact factor: 2.698
Figure 1Tooth color assessment devices. (a) Custom silicone matrix covering the entire buccal tooth’s surface, (b,c) with a perforation to fit the spectrophotometer tip.
Color shades of the samples according to VITA Classical A1–D4® Shade Guide throughout the experiment.
| GROUP | SAMPLE | BASELINE | INTRACANAL MEDICATION | CERVICAL SEALING | BLEACHING | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1w | 1m | 2m | 4m | 1w | 1m | 2m | SESSION1 | SESSION2 | ||||
| TAP | 1 | B1 | B2 | B2 | B2 | B2 | B2 | B2 | B2 | B2 | A1 | GIC |
| 2 | A1 | B2 | B2 | B2 | B2 | B2 | B2 | B2 | B2 | A1 | ||
| 3 | A2 | B2 | B2 | B2 | B2 | B3 | B2 | B2 | B2 | A1 | ||
| 4 | B2 | B2 | B2 | B2 | B2 | B3 | B2 | B2 | A1 | A1 | ||
| 5 | A2 | A2 | A2 | B2 | B2 | A2 | B2 | B3 | A2 | A2 | ||
| 6 | A1 | B2 | B2 | B2 | B2 | B3 | B3 | B3 | A1 | A1 | MTA | |
| 7 | B1 | B2 | B2 | B2 | B2 | B2 | B3 | B2 | B2 | B2 | ||
| 8 | A2 | A2 | A2 | A2 | B2 | B3 | B3 | B3 | B2 | B2 | ||
| 9 | A1 | B2 | B2 | B2 | B2 | B2 | B2 | B2 | A1 | B2 | ||
| 10 | A2 | A2 | A2 | A2 | B2 | B3 | B3 | B3 | B2 | B2 | ||
| TAPM | 11 | B2 | B2 | A1 | A1 | B2 | B2 | B2 | B2 | A1 | A1 | GIC |
| 12 | A1 | A1 | A1 | A2 | A1 | B2 | B2 | B2 | A1 | A1 | ||
| 13 | B2 | B2 | B2 | B2 | B2 | B2 | B2 | B2 | B2 | A1 | ||
| 14 | A2 | A2 | A2 | B2 | B2 | A2 | A2 | B2 | B2 | B2 | ||
| 15 | A2 | A2 | A2 | A2 | A2 | A2 | A2 | A2 | B2 | A1 | ||
| 16 | A1 | A1 | A1 | A1 | A1 | B2 | B2 | B2 | B2 | B2 | MTA | |
| 17 | A3 | A3 | A3 | A3 | A3 | B3 | B3 | B3 | B3 | B3 | ||
| 18 | A2 | A3 | A2 | A3 | A2 | A3 | B3 | B3 | B3 | B2 | ||
| 19 | A2 | A3 | A3 | A3 | A2 | B3 | B3 | B3 | B3 | B3 | ||
| 20 | A1 | A1 | A1 | B2 | B2 | B2 | B2 | B2 | A1 | A1 | ||
| DAB | 21 | A2 | A2 | B2 | A2 | A2 | B3 | B2 | B3 | A2 | B2 | GIC |
| 22 | A1 | A1 | A1 | B2 | B2 | B2 | B2 | B2 | A1 | B1 | ||
| 23 | A1 | A1 | A1 | B2 | B2 | B2 | B2 | B2 | B1 | B1 | ||
| 24 | B2 | B2 | A2 | A2 | B2 | B3 | B2 | B2 | B2 | A1 | ||
| 25 | B2 | B2 | B1 | B2 | B2 | B2 | B2 | B2 | A1 | A1 | ||
| 26 | A3 | A2 | A3 | B3 | B3 | B3 | B3 | B3 | B3 | B3 | MTA | |
| 27 | A2 | A2 | A2 | A2 | A2 | B2 | B2 | B3 | B2 | B2 | ||
| 28 | A3.5 | A3.5 | A3.5 | A.35 | A3.5 | A3.5 | A3.5 | B4 | B3 | B3 | ||
| 29 | B2 | B2 | B2 | B2 | B2 | B2 | B2 | B2 | A1 | A1 | ||
| 30 | A1 | A2 | B2 | A2 | B2 | B3 | B2 | B2 | B2 | B2 | ||
| CH | 31 | B1 | B2 | B2 | B2 | B2 | B2 | B2 | B2 | B2 | A1 | GIC |
| 32 | A1 | B2 | B2 | B2 | B3 | B2 | B2 | B2 | A1 | A1 | ||
| 33 | A1 | B2 | B2 | B2 | B2 | B2 | B2 | B2 | B2 | B2 | ||
| 34 | B2 | B2 | B2 | B2 | B2 | B3 | B2 | B2 | B2 | A1 | ||
| 35 | A2 | A2 | B2 | B2 | B2 | B2 | B2 | B2 | B2 | B2 | ||
| 36 | B2 | B2 | B2 | B2 | B2 | B2 | B2 | B2 | B2 | B2 | MTA | |
| 37 | A1 | B2 | B2 | B2 | B2 | B2 | B2 | B2 | B2 | B2 | ||
| 38 | A2 | B3 | B3 | B3 | B3 | B3 | B3 | B3 | B2 | B2 | ||
| 39 | A2 | A3 | A3 | B3 | B2 | B3 | B3 | B3 | B3 | B3 | ||
| 40 | A2 | A2 | B2 | B2 | B2 | B3 | B2 | B2 | B2 | B2 | ||
| Control | 41 | B2 | B2 | B2 | B2 | A1 | B2 | B2 | B2 | B2 | B2 | UT |
| 42 | A1 | A1 | A1 | B2 | A2 | B2 | A1 | A1 | A1 | A1 | ||
| 43 | A2 | A2 | A2 | A2 | B2 | B2 | B2 | B2 | B2 | B2 | ||
| 44 | A1 | A1 | A1 | C2 | A1 | B2 | A1 | B2 | A1 | A1 | ||
| 45 | A2 | A2 | A1 | A2 | B2 | B2 | B2 | B2 | B2 | B2 | ||
| 46 | B2 | B2 | B2 | A3 | B2 | B2 | B2 | B2 | B2 | B2 | ||
| 47 | A1 | A1 | A1 | B2 | A1 | B2 | A1 | A1 | A1 | A1 | ||
| 48 | A2 | A2 | A2 | B2 | B2 | B2 | B2 | B2 | B2 | B2 | ||
| 49 | A1 | A1 | A1 | A2 | A2 | B2 | A1 | B2 | A1 | B2 | ||
| 50 | B2 | A2 | A2 | B2 | A1 | B2 | B2 | B2 | B2 | B2 | ||
CH: calcium hydroxide, DAP: double antibiotic paste, TAP: triple antibiotic paste, TAPM: TAP modified. GIC: glass ionomer cement, MTA: mineral trioxide aggregate, UT: untreated. d: day, m: month, w: week.
Mean values of ΔE and confidence intervals according to treatment and period of evaluation regarding Phase 1 (Intracanal medication)
| Treatments | ΔE Mean |
|---|---|
| TAP M | 3.5±0.5a |
| CONTROL | 5.25±1.7ab |
| DAB | 5.68±2.2ab |
| CH | 6.16±1.9ab |
| TAP | 8.06±1.5b |
| Periods | ΔE Mean |
| 1d | 4.21±2.9a |
| 3d | 4.38±2.6a |
| 1w | 4.42±2.8a |
| 2w | 4.52±3.3ac |
| 1m | 5.83±5.1ade |
| 3w | 6.15±3.0bd |
| 4m | 7.03±5.2bce |
| 2m | 7.34±5.9be |
| 3m | 7.69±5.4b |
ΔE: color change. CH: calcium hydroxide, DAP: double antibiotic paste, TAP: triple antibiotic paste, TAPM: TAP Modified. d: day, m: month, w: week. Treatment (P=0.019). Period (P<0.001). Equal letters indicate statistic equivalence.
Figure 2Graphic illustrating ΔE means from each group and period throughout Phase 1
Mean values of ΔE and standard deviation in Phase 2 (Treatment*Periods) and in Phase 3 (Treatment*Bleaching)
| TAP | TAPM | DAP | CH | Control | |||||
|---|---|---|---|---|---|---|---|---|---|
| GIC | MTA | GIC | MTA | GIC | MTA | GIC | MTA | ||
| Period/th> | Phase 2. Cervical Sealing | ||||||||
| Baseline | 7.77±0.9abA | 9.74±5.8abA | 3.46±1.3aA | 4.23±2.2acA | 2.66±1.4abA | 11.94±11.0abA | 10.48±5.3acfA | 7.73±4.6acdA | 6.17±2.7acA |
| 1d | 7.29±1.3abAF | 10±5.5aACF | 3.73±2.6aA | 3.85±0.9aA | 10.18±1.5aAE | 12.12±3.8aDEF | 13.98±1.8aDEF | 15.71±3.3aBCE | 13.61±3.4bBCE |
| 3d | 6.65±4.4aAE | 11.83±3.2abA | 9.01±2.0cAC | 8.66±1.6cAD | 3.66±1.5bBCDE | 7.9±2.5bcAE | 7.96±2.4bcAE | 8.88±3.2bcAE | 5.72±1.3aBCDE |
| 1w | 10.41±6.6bA | 14.47±4.1abA | 12.31±0.3bA | 13.27±0.6bA | 10.07±1.3acA | 10.68±5.5acdA | 11.86±1.3adA | 11.96±2.6acA | 9.4±2.6cA |
| 2w | 6.04±2.7aA | 12.31±5.0abBC | 4.26±0.3aA | 5.98±0.8aA | 2.56±0.7bA | 6.23±1.7bA | 7.45±2.4beAC | 6.87±2.6bdA | 4.34±1.5aA |
| 3w | 7.42±0.4abAB | 12.45±5.2abA | 2.55±1.1aB | 4.17±1.0acB | 2.53±1.3bB | 5.1±2.9bdAB | 6.59±3.0bdfAB | 8.91±8.5bcAB | 4.34±1.6acB |
| 1m | 8.21±2.0abAC | 15.8±9.4bA | 2.70±0.4aBC | 4.86±0.7acBC | 2.49±0.5bBC | 5.18±2.3bdBC | 10±3.6acefAC | 6.26±2.9bcBC | 4.57±1.7aBC |
| 2m | 9.13±1.8abAC | 13.72±5.5abA | 3.63±1.4aBC | 6.04±1.8acBC | 4.75±2.2bcBC | 7.18±2.0bdBC | 9.36±3.3acefAC | 8.23±3.1bcAC | 6.33±2.1acBC |
|
| |||||||||
|
|
| ||||||||
|
| |||||||||
| Baseline | 9.13±1.8aAB | 13.72±5.5aA | 3.63±1.4aB | 6.04±1.8aB | 4.75±2.2aB | 7.18±2.0aB | 9.36±3.3aAB | 8.23±3.1acAB | 6.33±2.1aB |
| B1 | 5.05±2.4bA | 6.87±5.2bA | 4.76±2.5aA | 4.19±0.7aA | 4.88±2.2aA | 7.1±3.8aA | 5.54±2.1bA | 6.74±1.5aA | 5.93±1.3aA |
| B2 | 4.93±2.1bA | 6.48±3.4bA | 5.59±2.2aA | 4.65±08aA | 6.88±1.5aA | 6.33±5.5aA | 4.19±1.5bA | 9.87±4.9bcA | 6.67±2.3aA |
ΔE: color change. B1: bleaching 1, B2: bleaching 2. CH: calcium hydroxide, DAP: double antibiotic paste, TAP: triple antibiotic paste, TAPM: TAP modified. GIC: glass ionomer cement, MTA: mineral trioxide aggregate. d: day, m: month, w: week. For comparisons, lowercase letters were used within the columns and uppercase letters within the rows. Equal letters indicate statistic equivalence. Phase 2: Treatment*Period (P<0.001). Phase 3: Treatment*Bleaching (P<0.001).
Figure 3Graphic illustrating ΔE means from each group and period throughout Phase 2
Figure 4Graphic illustrating ΔE means from each group and period throughout Phase 3